MERCK signed collaboration agreement with Sysmex Inostics GmbH for the development and commercialization of a blood-based RAS biomarker test for patients with metastatic colorectal cancer.
MEMORIAL SLOAN KETTERING CANCER CENTER and Quest Diagnostics announced a joint collaboration that will focus on gene mutations associated with solid tumors. Financial terms of the agreement were not disclosed.
ASTRAZENECA CAMCAR, S.A., a division of AstraZeneca focused in Central American and Caribbean countries, has partnered with Cancer Genetics Inc. to provide biomarker-based diagnostic testing for cancer.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL's comprehensive cancer center designation was renewed by NCI.
ANDREW KRAFT was named director of the University of Arizona Cancer Center and associate vice president for oncology programs for the University of Arizona Health Sciences Center.
THE CANCER LETTER received a first place 2014 Dateline Award for Excellence in Local Journalism from the Society of Professional Journalists June 10. The award recognizes Paul Goldberg's series of stories on “Conflict of Interest at MD Anderson Cancer Center” as the winner in the Newsletter, Washington, D.C., category.
THE ASSOCIATION OF CLINICAL RESEARCH PROFESSIONALS Certified Clinical Research Coordinatordesignation is now recognized by the American Nurses Credentialing Center as a valid designation toward meeting staffing requirements of theANCC Magnet Recognition Program.
GEORGETOWN LOMBARDI COMPREHENSIVE CANCER CENTER and JOHN THEURER CANCER CENTER formed an immunotherapy research collaboration.
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO is encouraging cancer researchers to recruit more Hispanics in clinical trials to reduce health disparities.
THE NATIONAL PATIENT ADVOCATE FOUNDATION has launched Project Innovation, a movement to accelerate the pace of cancer medical discovery and to get therapies to patients quickly.
